The Oncoguard® Liver test detects early-stage HCC with high sensitivity across patient subgroups
July 19, 2022
David J Kim, MD
Illinois Gastro Group
Please join us for this webinar as we:
- Learn to understand & differentiate the warning signs with appropriate testing for patients with abnormal liver enzymes.
- Learn to identify patients with cirrhosis.
- Discover pathways to management and surveillance.
- Explore the comorbidities of cirrhosis.